Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous deferoxamine dose-escalation study in acute ischemic stroke treated with tPA
2007-006731-31Phase 2Active
- Sponsor
- Germans Trias i Pujol Research Institute
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Deferoxamine plus standard alteplase with Placebo plus standard alteplase (2 arms). Primary endpoints: Safety adverse events, Laboratory safety and 4 more. Started Jan 2008; status: active.
02
Drugs
deferoxamine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2007-006731-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006731-31.